Magnetoliposomes containing magnesium ferrite nanoparticles as nanocarriers for the mode drug curcumin

Magnesium ferrite nanoparticles, with diameters around 25 nm, were synthesized by coprecipitation method. The magnetic properties indicate a superparamagnetic behavior, with a maximum magnetization of 16.2 emu/g, a coercive field of 22.1 Oe and a blocking temperature of 183.2 K. These MgFe2O4 nanopa...

Full description

Bibliographic Details
Main Author: Cardoso, Beatriz D. (author)
Other Authors: Rio, Irina S. R. (author), Rodrigues, Ana Rita Oliveira (author), Fernandes, Francisca C. T. (author), Almeida, B. G. (author), Pires, A. (author), Pereira, A. M. (author), Araújo, J. P. (author), Castanheira, Elisabete M. S. (author), Coutinho, Paulo J. G. (author)
Format: article
Language:eng
Published: 2018
Subjects:
Online Access:http://hdl.handle.net/1822/56615
Country:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/56615
Description
Summary:Magnesium ferrite nanoparticles, with diameters around 25 nm, were synthesized by coprecipitation method. The magnetic properties indicate a superparamagnetic behavior, with a maximum magnetization of 16.2 emu/g, a coercive field of 22.1 Oe and a blocking temperature of 183.2 K. These MgFe2O4 nanoparticles were used to produce aqueous and solid magnetoliposomes, with sizes below 130 nm. The potential drug curcumin was successfully incorporated in these nanosystems, with high encapsulation efficiencies (above 89%). Interaction by fusion between both types of drug loaded magnetoliposomes (with or without PEGylation) and models of biological membranes was demonstrated, using FRET or fluorescence quenching assays. These results point to future applications of magnetoliposomes containing MgFe2O4 nanoparticles in cancer therapy, allowing combined magnetic hyperthermia and chemotherapy.